Entourage Health Corp
XTSX:ENTG
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.005
0.005
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CAD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Operating Margin
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Peer Comparison
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| CA |
E
|
Entourage Health Corp
XTSX:ENTG
|
1.5m CAD |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1T USD |
Loading...
|
|
| UK |
D
|
Dechra Pharmaceuticals PLC
F:1PK
|
5.1B EUR |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
528.7B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
275.3B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
210.3B GBP |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.8T DKK |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
221.9B CHF |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
267.9B USD |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
145.6B USD |
Loading...
|
Market Distribution
| Min | -4 710 029.9% |
| 30th Percentile | -65.8% |
| Median | -2.4% |
| 70th Percentile | 11% |
| Max | 71 100% |
Other Profitability Ratios
Entourage Health Corp
Glance View
Entourage Health Corp. engages in the production and distribution of cannabis products for both the medical and adult-use markets. The company is headquartered in Aylmer, Ontario and currently employs 251 full-time employees. The company went IPO on 2014-11-13. The firm owns and operates two facilities, an approximately 26,000 square feet (sq. ft.) indoor facility in Aylmer, Ontario (Aylmer Facility), which specializes in cannabis extraction and processing; and an approximately 158 acres property with up to approximately 550,000 sq. ft. of state-of-the-art greenhouses and approximately 100 acres of outdoor facility located in Strathroy, Ontario. The company has approximately 300,000 sq. ft. of indoor, including warehouse and hybrid greenhouse licensed production space and approximately 27 acres of outdoor licensed production space across its sites. The firm sales through multi-channeled distribution, which includes selling directly to medical patients, strategic relationships across the market and supply agreements with Shoppers Drug Mart, as well as eight provincial distribution agencies.
See Also
Operating Margin is calculated by dividing the Operating Income by the Revenue.
The current Operating Margin for Entourage Health Corp is -34.4%, which is above its 3-year median of -67.1%.
Over the last 3 years, Entourage Health Corp’s Operating Margin has increased from -222.8% to -34.4%. During this period, it reached a low of -222.8% on Sep 30, 2021 and a high of -34.4% on Sep 30, 2024.